SA

Salam Abdul Kareem

Director Director DIN 01742027
DIN 01742027 First appointment Mar 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2008
Shareholding value Locked Premium profile

About Salam Abdul Kareem

Data last updated:

Salam Abdul Kareem has 18 years in corporate governance. Formerly with 1 company, such as Hubris Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01742027
Primary Designation Director
First Appointment 20 Mar 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director20 Mar 20082007Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hubris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Salam Abdul Kareem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Salam Abdul Kareem

Salam Abdul Kareem has 18 years in corporate governance. Formerly with 1 company, such as Hubris Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Salam Abdul Kareem is associated with 0 companies as a director.

Salam Abdul Kareem has expertise in General Business.

Salam Abdul Kareem has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available